Peer-reviewed veterinary case report
Rush allergy shots safely reduce itching in dogs with atopic
By Mueller, Ralf & Hobi, S.·Published in Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere·2014·View original on Crossref →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Efficacy and safety of rush immunotherapy with alumprecipitated allergens in canine atopic dermatitis
- Species:
- dog
Plain-English summary
A group of 20 dogs with atopic dermatitis (a common skin allergy causing itching) underwent a new treatment called rush immunotherapy, which involves giving increasing doses of allergens quickly. After 12 months, 70% of the dogs showed significant improvement in their itching and needed less medication. One dog experienced mild vomiting during the treatment, but all others had no side effects. Overall, this method appears to be a safe and effective way to help dogs with this skin condition feel better.
People also search for: dog itching treatment · rush immunotherapy for dogs · atopic dermatitis in dogs · dog allergy shots · dog skin problems relief
Abstract
Summary Objectives: Canine atopic dermatitis is a very common disease in small animal practice. Its only specific treatment is allergen immunotherapy. In rush-immunotherapy (RIT) increasing doses of allergen extract are injected subcutaneously in short intervals. Maintenance doses are achieved within one day compared to weeks or months with conventional immunotherapy. The aim of this study was to evaluate the safety and efficacy of RIT with alum-precipitated allergens. Materials and methods: A series of 20 dogs with atopic dermatitis underwent RIT with alum-precipitated allergens. Pruritus and medications at the start of the immunotherapy and 12 months afterwards were compared and adverse effects were recorded. Results: Significant improvement in pruritus (p = 0.0001) and medication scores (p = 0.0004) was noted after approximately 12 months of treatment. The observed clinical response was good to excellent in 70% of the dogs, consistent with other published reports. One dog vomited once during the induction day, with no other clinical problems and completion of the normal protocol. The other 19 dogs showed no adverse effects at all during or after RIT. Conclusion and clinical relevance: RIT with alum-precipitated allergens seems to be a safe and efficacious method to treat dogs with atopic dermatitis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Crossref: https://doi.org/10.1055/s-0038-1623762